Raza, Muhammad H.
Tiao, Jonathan R.
Wang, Catherine K.
Luk, Lyndon
Doyle, John B.
Sugahara, Kazuki N.
Schrope, Beth A.
Kluger, Michael D.
Chabot, John A.
Manji, Gulam
Gonda, Tamas A.
Welinsky, Sara
Poneros, John M.
Sethi, Amrita
Visrodia, Kavel H.
Article History
Received: 14 December 2025
Accepted: 24 April 2026
First Online: 2 June 2026
Declarations
:
: Dr. Muhammad H. Raza, Dr. Jonathan R. Tiao, Dr. Catherine K. Wang, Dr. Lyndon Luk, Dr. John B. Doyle, Dr. Kazuki N. Sugahara, Dr. Beth A. Schrope, Dr. Michael D. Kluger, Dr. John A. Chabot, Dr. Sara Welinsky, and Dr. John M. Poneros have no conflicts of interest to disclose. Dr. Gulam Manji reports research funding from Genentech Roche, Merck, Plexxikon, Regeneron, and BioLineRx, and serves as a consultant for Arcus Bioscience, BioLineRx, Ipsen, and EnGeneIC Inc., and on advisory boards for Pfizer, Revolution Medicine, and CEND Pharm. Dr. Tamas A. Gonda reports consultancy for Boston Scientific. Dr. Amrita Sethi reports consultancy for Boston Scientific, Cook, Medtronic, and Olympus, and serves on advisory boards for GI Scientific and Endosound. Dr. Kavel H. Visrodia reports consultancy for Boston Scientific, Olympus, and Pentax.